(IR) Ingersoll Rand - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US45687V1061
Stock: Compressors, Pumps, Blowers, Power Tools, Vacuum
Total Rating 42
Risk 79
Buy Signal 0.05
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.09% |
| Yield on Cost 5y | 0.18% |
| Yield CAGR 5y | 41.42% |
| Payout Consistency | 83.7% |
| Payout Ratio | 3.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 29.4% |
| Relative Tail Risk | -8.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | -11.14 |
| Character TTM | |
|---|---|
| Beta | 1.185 |
| Beta Downside | 1.121 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.62% |
| CAGR/Max DD | 0.56 |
Description: IR Ingersoll Rand December 17, 2025
Ingersoll Rand Inc. (NYSE: IR) operates globally in two core segments: Industrial Technologies & Services, which supplies air- and gas-compression, vacuum, blower, fluid-transfer, power-tool and lifting equipment (including aftermarket parts and services) under brands such as Gardner Denver, CompAir and Elmo Rietschle; and Precision & Science Technologies, which delivers high-precision pumps, hydrogen compressors, liquid-handling and dosing systems for medical, life-science, industrial and energy markets under brands like Haskel, Milton Roy and LMI.
Key recent metrics show FY 2023 revenue of roughly $13.5 billion, a free-cash-flow conversion of ≈ 85 % of operating cash flow, and an operating margin of ≈ 13 %, with aftermarket services contributing about 30 % of total sales and delivering higher margin stability. The segment’s hydrogen-compression portfolio is benefitting from the global decarbonization push, while the broader industrial-equipment market remains sensitive to U.S. construction-spending cycles and capital-expenditure trends in manufacturing.
For a deeper, data-driven look at how these dynamics translate into valuation risk and upside, you may find a quick scan on ValueRay worth a look.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 545.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.64 > 1.0 |
| NWC/Revenue: 30.00% < 20% (prev 33.75%; Δ -3.74% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.38b > Net Income 545.1m |
| Net Debt (3.68b) to EBITDA (1.67b): 2.21 < 3 |
| Current Ratio: 2.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (400.5m) vs 12m ago -1.57% < -2% |
| Gross Margin: 43.72% > 18% (prev 0.44%; Δ 4329 % > 0.5%) |
| Asset Turnover: 40.98% > 50% (prev 39.32%; Δ 1.67% > 0%) |
| Interest Coverage Ratio: 4.69 > 6 (EBITDA TTM 1.67b / Interest Expense TTM 250.8m) |
Altman Z'' 2.09
| A: 0.12 (Total Current Assets 4.16b - Total Current Liabilities 1.93b) / Total Assets 18.19b |
| B: 0.15 (Retained Earnings 2.79b / Total Assets 18.19b) |
| C: 0.06 (EBIT TTM 1.18b / Avg Total Assets 18.20b) |
| D: 0.33 (Book Value of Equity 2.63b / Total Liabilities 8.00b) |
| Altman-Z'' Score: 2.09 = BBB |
Beneish M -3.02
| DSRI: 1.02 (Receivables 1.43b/1.34b, Revenue 7.46b/7.16b) |
| GMI: 1.00 (GM 43.72% / 43.81%) |
| AQI: 1.00 (AQ_t 0.72 / AQ_t-1 0.72) |
| SGI: 1.04 (Revenue 7.46b / 7.16b) |
| TATA: -0.05 (NI 545.1m - CFO 1.38b) / TA 18.19b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of IR shares?
As of February 08, 2026, the stock is trading at USD 98.50 with a total of 6,260,059 shares traded.
Over the past week, the price has changed by +14.42%, over one month by +18.06%, over three months by +26.83% and over the past year by +6.74%.
Over the past week, the price has changed by +14.42%, over one month by +18.06%, over three months by +26.83% and over the past year by +6.74%.
Is IR a buy, sell or hold?
Ingersoll Rand has received a consensus analysts rating of 3.94.
Therefore, it is recommended to buy IR.
- StrongBuy: 7
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 90.2 | -8.5% |
| Analysts Target Price | 90.2 | -8.5% |
| ValueRay Target Price | 111.8 | 13.5% |
IR Fundamental Data Overview February 03, 2026
P/E Trailing = 65.7176
P/E Forward = 24.2131
P/S = 4.5877
P/B = 3.4689
P/EG = 1.1766
Revenue TTM = 7.46b USD
EBIT TTM = 1.18b USD
EBITDA TTM = 1.67b USD
Long Term Debt = 4.79b USD (from longTermDebt, last quarter)
Short Term Debt = 65.6m USD (from shortTermDebt, last quarter)
Debt = 4.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.68b USD (from netDebt column, last quarter)
Enterprise Value = 37.89b USD (34.22b + Debt 4.85b - CCE 1.18b)
Interest Coverage Ratio = 4.69 (Ebit TTM 1.18b / Interest Expense TTM 250.8m)
EV/FCF = 30.33x (Enterprise Value 37.89b / FCF TTM 1.25b)
FCF Yield = 3.30% (FCF TTM 1.25b / Enterprise Value 37.89b)
FCF Margin = 16.75% (FCF TTM 1.25b / Revenue TTM 7.46b)
Net Margin = 7.31% (Net Income TTM 545.1m / Revenue TTM 7.46b)
Gross Margin = 43.72% ((Revenue TTM 7.46b - Cost of Revenue TTM 4.20b) / Revenue TTM)
Gross Margin QoQ = 43.74% (prev 43.69%)
Tobins Q-Ratio = 2.08 (Enterprise Value 37.89b / Total Assets 18.19b)
Interest Expense / Debt = 1.34% (Interest Expense 65.1m / Debt 4.85b)
Taxrate = 23.04% (73.6m / 319.4m)
NOPAT = 905.4m (EBIT 1.18b * (1 - 23.04%))
Current Ratio = 2.16 (Total Current Assets 4.16b / Total Current Liabilities 1.93b)
Debt / Equity = 0.48 (Debt 4.85b / totalStockholderEquity, last quarter 10.12b)
Debt / EBITDA = 2.21 (Net Debt 3.68b / EBITDA 1.67b)
Debt / FCF = 2.94 (Net Debt 3.68b / FCF TTM 1.25b)
Total Stockholder Equity = 10.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.00% (Net Income 545.1m / Total Assets 18.19b)
RoE = 5.33% (Net Income TTM 545.1m / Total Stockholder Equity 10.22b)
RoCE = 7.84% (EBIT 1.18b / Capital Employed (Equity 10.22b + L.T.Debt 4.79b))
RoIC = 6.04% (NOPAT 905.4m / Invested Capital 14.99b)
WACC = 9.13% (E(34.22b)/V(39.07b) * Re(10.28%) + D(4.85b)/V(39.07b) * Rd(1.34%) * (1-Tc(0.23)))
Discount Rate = 10.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF Debug] Terminal Value 77.67% ; FCFF base≈1.30b ; Y1≈1.60b ; Y5≈2.72b
Fair Price DCF = 85.40 (EV 37.42b - Net Debt 3.68b = Equity 33.74b / Shares 395.1m; r=9.13% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -1.01 | EPS CAGR: -41.73% | SUE: -4.0 | # QB: 0
Revenue Correlation: 90.98 | Revenue CAGR: 8.92% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.77 | Chg30d=-0.005 | Revisions Net=-2 | Analysts=9
EPS next Year (2026-12-31): EPS=3.56 | Chg30d=-0.018 | Revisions Net=-7 | Growth EPS=+8.4% | Growth Revenue=+4.7%
P/E Forward = 24.2131
P/S = 4.5877
P/B = 3.4689
P/EG = 1.1766
Revenue TTM = 7.46b USD
EBIT TTM = 1.18b USD
EBITDA TTM = 1.67b USD
Long Term Debt = 4.79b USD (from longTermDebt, last quarter)
Short Term Debt = 65.6m USD (from shortTermDebt, last quarter)
Debt = 4.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.68b USD (from netDebt column, last quarter)
Enterprise Value = 37.89b USD (34.22b + Debt 4.85b - CCE 1.18b)
Interest Coverage Ratio = 4.69 (Ebit TTM 1.18b / Interest Expense TTM 250.8m)
EV/FCF = 30.33x (Enterprise Value 37.89b / FCF TTM 1.25b)
FCF Yield = 3.30% (FCF TTM 1.25b / Enterprise Value 37.89b)
FCF Margin = 16.75% (FCF TTM 1.25b / Revenue TTM 7.46b)
Net Margin = 7.31% (Net Income TTM 545.1m / Revenue TTM 7.46b)
Gross Margin = 43.72% ((Revenue TTM 7.46b - Cost of Revenue TTM 4.20b) / Revenue TTM)
Gross Margin QoQ = 43.74% (prev 43.69%)
Tobins Q-Ratio = 2.08 (Enterprise Value 37.89b / Total Assets 18.19b)
Interest Expense / Debt = 1.34% (Interest Expense 65.1m / Debt 4.85b)
Taxrate = 23.04% (73.6m / 319.4m)
NOPAT = 905.4m (EBIT 1.18b * (1 - 23.04%))
Current Ratio = 2.16 (Total Current Assets 4.16b / Total Current Liabilities 1.93b)
Debt / Equity = 0.48 (Debt 4.85b / totalStockholderEquity, last quarter 10.12b)
Debt / EBITDA = 2.21 (Net Debt 3.68b / EBITDA 1.67b)
Debt / FCF = 2.94 (Net Debt 3.68b / FCF TTM 1.25b)
Total Stockholder Equity = 10.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.00% (Net Income 545.1m / Total Assets 18.19b)
RoE = 5.33% (Net Income TTM 545.1m / Total Stockholder Equity 10.22b)
RoCE = 7.84% (EBIT 1.18b / Capital Employed (Equity 10.22b + L.T.Debt 4.79b))
RoIC = 6.04% (NOPAT 905.4m / Invested Capital 14.99b)
WACC = 9.13% (E(34.22b)/V(39.07b) * Re(10.28%) + D(4.85b)/V(39.07b) * Rd(1.34%) * (1-Tc(0.23)))
Discount Rate = 10.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF Debug] Terminal Value 77.67% ; FCFF base≈1.30b ; Y1≈1.60b ; Y5≈2.72b
Fair Price DCF = 85.40 (EV 37.42b - Net Debt 3.68b = Equity 33.74b / Shares 395.1m; r=9.13% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -1.01 | EPS CAGR: -41.73% | SUE: -4.0 | # QB: 0
Revenue Correlation: 90.98 | Revenue CAGR: 8.92% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.77 | Chg30d=-0.005 | Revisions Net=-2 | Analysts=9
EPS next Year (2026-12-31): EPS=3.56 | Chg30d=-0.018 | Revisions Net=-7 | Growth EPS=+8.4% | Growth Revenue=+4.7%